Synbiotics, particularly the combination of Human Milk Oligosaccharides (HMOs) and probiotics, have emerged as a key focus area for innovation pioneered by the infant nutrition sector. Additionally, emerging science indicates that synbiotic solutions may also support health across all stages of life.
Join this webinar, featuring expert speakers from the Novonesis Human Health Biosolutions team, to learn more about our newest synbiotic solution for infant health and our synbiotic portfolio spanning across health areas and life stages.

Claudia Stoecker
Head of B2B Portfolio Execution

Jolanda van Hal
Senior Journalist

Stine Ninel Hansen
Global Scientific Advisor

Claudia Stoecker
Head of B2B Portfolio Execution

Jolanda van Hal
Senior Journalist

Stine Ninel Hansen
Global Scientific Advisor
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight
















